Fredrik Bäckström
Geen lopende functies
Vermogen: 33 957 $ op 31-03-2024
Profiel
Fredrik Bäckström worked as the Vice President-Product Supply at Arcam AB from 2013 to 2019.
He also held the position of Vice President-Manufacturing & Supply at Carmel Pharma AB from 2000 to 2011.
Currently, he is serving as the Chief Operating Officer at Bulten AB, a position he started in 2019 and will continue until 2023.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BULTEN AB
0.02% | 25-08-2023 | 4 940 ( 0.02% ) | 33 957 $ | 31-03-2024 |
Eerdere bekende functies van Fredrik Bäckström
| Bedrijven | Functie | Einde |
|---|---|---|
| BULTEN AB | Chief Operating Officer | 01-08-2023 |
| ARCAM AB (PUBL) | Corporate Officer/Principal | 01-12-2019 |
Carmel Pharma AB
 Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BULTEN AB | Producer Manufacturing |
| Bedrijven in privébezit | 2 |
|---|---|
Arcam AB
 Arcam AB Industrial MachineryProducer Manufacturing Arcam AB engages in the development and commercialization of technologies for metal-based, freedom-in-design manufacturing. It develops, manufactures, and sells equipment and methods for Additive Manufacturing in metal. The company was founded in 1997 and is headquartered in Molndal, Sweden. | Producer Manufacturing |
Carmel Pharma AB
Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden. | Electronic Technology |
